Muhlenkamp & Co. Inc.
Wexford, PA 19 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $345M
- 28 holdings
- 2026 Q2
- −9.2% QoQ
- Top 5 31.7%
AUM over time
Book
| WCC, Wesco International | Reduce −0.3% | 130,199 | $131.59 | $17M | −376 | +$2.1M | |
| MCK, McKesson | Reduce −0.1% | 65,500 | $248.56 | $16M | −48 | +$3.2M | |
| MSFT, Microsoft | Reduce −0.1% | 44,675 | $336.32 | $15M | −26 | +$2.4M | |
| MCHP, Microchip Technology | Add +76.2% | 167,222 | $87.06 | $15M | +72,311 | −$10K | |
| AVGO, Broadcom | Reduce −10.3% | 21,852 | $665.43 | $15M | −2,518 | +$2.7M | |
| AAPL, Apple | Reduce −0.1% | 79,565 | $177.57 | $14M | −44 | +$2.9M | |
| RUSHA, Rush Enterprises | Reduce −24.7% | 239,346 | $55.64 | $13M | −78,365 | −$1M | |
| DOW, DOW Inc | Reduce 0.0% | 217,226 | $56.72 | $12M | −93 | −$188K | |
| UNH, UnitedHealth Group | Reduce −0.1% | 24,396 | $502.13 | $12M | −16 | +$2.7M | |
| MTZ, Mastec | Reduce −0.1% | 128,539 | $92.28 | $12M | −95 | +$763K | |
| MTH, Meritage Homes | Reduce −0.1% | 96,574 | $122.06 | $12M | −63 | +$2.4M | |
| CVS, CVS Health | Reduce 0.0% | 108,633 | $103.16 | $11M | −12 | +$2M | |
| BRK.B, Berkshire Hathaway | Reduce 0.0% | 36,971 | $298.99 | $11M | −4 | +$962K | |
| KEX, Kirby | Reduce −0.1% | 164,716 | $59.42 | $9.8M | −135 | +$1.9M | |
| EQT | New | 444,283 | $21.81 | $9.7M | +444,283 | +$9.7M | |
| SLB | Reduce −0.1% | 310,127 | $29.95 | $9.3M | −249 | +$88K | |
| AMLP, Alps ETF Trust | Reduce −0.1% | 280,200 | $32.74 | $9.2M | −236 | −$173K | |
| BFH, Alliance Data Systems | Reduce −0.1% | 124,816 | $66.57 | $8.3M | −104 | −$4.3M | |
| LEN, Lennar | Reduce −0.1% | 68,236 | $116.16 | $7.9M | −58 | +$1.5M | |
| BMY, Bristol Myers Squibb | Add +0.5% | 125,987 | $62.35 | $7.9M | +568 | +$434K | |
| NMIH, Nmi | Add +0.2% | 330,870 | $21.85 | $7.2M | +809 | −$233K | |
| LMT, Lockheed Martin | Add +0.6% | 19,427 | $355.43 | $6.9M | +108 | +$238K | |
| Tenneco | Reduce −0.1% | 574,720 | $11.30 | $6.5M | −699 | −$1.7M | |
| WAB, Wabtec | Reduce −0.2% | 55,193 | $92.11 | $5.1M | −83 | +$319K | |
| FNV, Franco Nev | Add +67.1% | 34,839 | $138.29 | $4.8M | +13,986 | +$2.1M | |
| RGLD, Royal Gold | Add +69.7% | 41,334 | $105.22 | $4.3M | +16,984 | +$2M | |
| CCJ, Cameco | Reduce −57.2% | 160,916 | $21.81 | $3.5M | −214,859 | −$4.7M | |
| Equity Comwlth | Reduce −0.1% | 112,855 | $25.90 | $2.9M | −88 | −$11K | |
| GLD, SPDR Gold Shares | Reduce −62.1% | 15,745 | $170.97 | $2.7M | −25,767 | −$4.1M | |
| Loyalty Ventures | New | 49,222 | $30.07 | $1.5M | +49,222 | +$1.5M | |
| PFE, Pfizer | Hold | 24,379 | $59.07 | $1.4M | — | — | |
| MS, Morgan Stanley | Hold | 10,805 | $98.20 | $1.1M | — | — | |
| IVZ, Invesco | New | 5,699 | $96.51 | $550K | +5,699 | +$550K | |
| EPD, Enterprise Products Partners | Hold | 24,855 | $21.97 | $546K | — | — | |
| RUSHB, Rush Enterprises | Hold | 6,742 | $53.99 | $364K | — | — |
Filings history
19 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 28 | $345M | −9.2% | 13F-HR | 8/17/2026 | 000113321926000003 |
| 2026 Q1 | 29 | $380M | +2.2% | 13F-HR | 5/6/2026 | 000113321926000002 |
| 2025 Q4 | 28 | $372M | +1.1% | 13F-HR | 2/4/2026 | 000113321926000001 |
| 2025 Q3 | 31 | $368M | +15.0% | 13F-HR | 11/7/2025 | 000113321925000006 |
| 2025 Q2 | 26 | $320M | +4.6% | 13F-HR | 7/24/2025 | 000113321925000005 |
| 2025 Q1 | 26 | $306M | −7.0% | 13F-HR | 5/13/2025 | 000113321925000004 |
| 2024 Q4 | 30 | $329M | +0.9% | 13F-HR | 2/13/2025 | 000113321925000001 |
| 2024 Q3 | 28 | $326M | +1.9% | 13F-HR | 11/12/2024 | 000113321924000004 |
| 2024 Q2 | 29 | $320M | −7.0% | 13F-HR | 7/17/2024 | 000113321924000003 |
| 2024 Q1 | 29 | $344M | +12.4% | 13F-HR | 4/23/2024 | 000113321924000002 |
| 2023 Q4 | 29 | $306M | +5.5% | 13F-HR | 1/8/2024 | 000113321924000001 |
| 2023 Q3 | 31 | $290M | +2.8% | 13F-HR | 12/6/2023 | 000113321923000005 |
| 2023 Q2 | 31 | $282M | +19.5% | 13F-HR | 7/14/2023 | 000113321923000004 |
| 2022 Q4 | 27 | $236M | +5.4% | 13F-HR | 1/31/2023 | 000113321923000003 |
| 2022 Q3 | 27 | $224M | +4.7% | 13F-HR | 11/1/2022 | 000113321922000004 |
| 2022 Q2 | 28 | $214M | −25.4% | 13F-HR | 7/18/2022 | 000113321922000003 |
| 2022 Q1 | 36 | $287M | 0.0% | 13F-HR | 4/1/2022 | 000113321922000002 |
| 2021 Q4 | 35 | $287M | +10.4% | 13F-HR | 3/29/2022 | 000113321922000001 |
| 2021 Q3 | 32 | $260M | — | 13F-HR | 12/10/2021 | 000113321921000007 |
About
Muhlenkamp & Co. Inc.
19 processed 13Fs on this site, 2021 Q3 to 2026 Q2